Virodhamine trifluoroacetate |
Katalog-Nr.GC50155 |
TFA salt of virodhamine, an endogenous cannabinoid receptor mixed agonist/antagonist
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1415264-56-0
Sample solution is provided at 25 µL, 10mM.
TFA salt of virodhamine, an endogenous cannabinoid receptor mixed agonist/antagonist that is found in higher concentrations peripherally than anandamide. Virodhamine is a full agonist at GPR55 and CB2 and partial agonist/antagonist at CB1 (EC50 values are 12, 381 and 2920 nM at GPR55, CB2 and CB1 receptors respectively).
Porter et al (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J.Pharmacol.Exp.Ther. 301 1020 PMID:12023533
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *